Decreased T-cell responses to influenza vaccination in patients with heart failure

Pharmacotherapy

Volumn 30, Issue 1, 2010, Pages 10-16

  Vardeny, Orly ^a   Moran, John J M ^a   Sweitzer, Nancy K ^b   Johnson, Maryl R ^b   Hayney, Mary S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

CHF; Chronic heart failure; Immune function; Immune response; Influenza vaccination; Vaccine

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIGEN;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELL ISOLATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HEART FAILURE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IN VIVO CULTURE; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MALE; MOUSE; NONHUMAN; OPEN STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; SCID MOUSE; SENSITIZATION; T LYMPHOCYTE;

ADULT; AGED; ANIMALS; ANTIBODIES, VIRAL; BIOLOGICAL ASSAY; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; HYPERSENSITIVITY, DELAYED; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; MALE; MICE; MICE, SCID; MIDDLE AGED; STATISTICS AS TOPIC; T-LYMPHOCYTES;

EID: 75149166609     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.30.1.10     Document Type: Article

References (25)

1. Fleming DM, Elliot AJ. The impact of influenza on the health and health care utilisation of elderly people. Vaccine 2005;23(suppl 1):S1-9.
2. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348(14):1322-32.
3. Ahmed AH, Nicholson KG, Nguyen-van Tam JS, Pearson JC. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiol Infect 1997;118(1):27-33.
4. Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005;165(3):274-80.
5. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112(12):e154-235.
6. Wahle M, Neumann RP, Moritz F, Krause A, Buttgereit F, Baerwald CG. Beta2-adrenergic receptors mediate the differential effects of catecholamines on cytokine production of PBMC. J Interferon Cytokine Res 2005;25(7):384-94.
7. Montminy M. Transcriptional regulation by cyclic AMP. Annu Rev Biochem 1997;66:807-22.
8. Hayney MS, Love GD, Buck JM, Ryff CD, Singer B, Muller D. The association between psychosocial factors and vaccine-induced cytokine production. Vaccine 2003;21(19-20): 2428-32.
9. Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine 1998;16(18):1722-31.
10. Deng Y, Jing Y, Campbell AE, Gravenstein S. Age-related impaired type 1 T cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 2004;172(6):3437-46.
11. McElhaney JE, Xie D, Hager WD, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006;176(10):6333-9.
12. McElhaney JE, Herre JM, Lawson ML, Cole SK, Burke BL, Hooton JW. Effect of congestive heart failure on humoral and ex vivo cellular immune responses to influenza vaccination in older adults. Vaccine 2004;22(5-6):681-8.
13. Vardeny O, Sweitzer NK, Detry MA, Moran JM, Johnson MR, Hayney MS. Decreased immune responses to influenza vaccination in patients with heart failure. J Card Fail 2009;15(4):368-73.
14. Hayney MS, Buck JM, Muller D. Production of interferon-γ and interleukin-10 after inactivated hepatitis A immunization. Pharmacotherapy 2003;23(4):431-5.
15. Hayney MS, Hammes RJ, Fine JP, Bianco JA. Effect of influenza immunization on CYP3A4 activity. Vaccine 2001;20(5-6): 858-61.
16. Hayney MS, Muller D. Effect of influenza immunization on CYP3A4 activity in vivo. J Clin Pharmacol 2003;43(12):1377-81.
17. Hayney MS, Moran J, Wiegert NA, Burlingham WJ. Lung transplant patients' T cell responses to influenza vaccine viruses between seasons. Vaccine 2008;26(21):2596-600.
18. Gross PA, Russo C, Teplitzky M, Dran S, Cataruozolo P, Munk G. Time to peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol 1996;3(3):361-2.
19. Levine M, Beattie BL, McLean DM, Corman D. Characterization of the immune response to trivalent influenza vaccine in elderly men. J Am Geriatr Soc 1987;35(7):609-15.
20. Phair J, Kauffman CA, Bjornson A, Adams L, Linnemann C Jr. Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med 1978;92(5):822-8.
21. Hayney MS, Welter DL, Francois M, Reynolds AM, Love RB. Influenza vaccine antibody responses in lung transplant recipients. Prog Transplant 2004;14(4):346-51.
22. Carrodeguas L, Orosz CG, Waldman WJ, Sedmak DD, Adams PW, VanBuskirk AM. Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum Immunol 1999;60(8):640-51.
23. Rodriguez DS, Jankowska-Gan E, Haynes LD, et al. Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching. Am J Transplant 2004;4(4):537-43.
24. Powers DC, Belshe RB. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J Infect Dis 1993;167(3):584-92.
25. Powers DC, Hanscome PJ, Pietrobon PJ. In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine 1995;13(14):1330-5.